Journal rankings · indicator year 2001
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2001
Biochemistry, Genetics and Molecular Biology journal rankings 2001
650 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 650 ranked journals in 2001. The median journal has an OJR of 0.63, below the world average of 1.00, up 0.01 on 2000; Q1 starts at OJR 1.14. The top three are Annual Review of Plant Physiology and Plant Molecular Biology, Cell, and Pharmacological Reviews.
Ranks and citation indicators: 2001. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1998–2000, the window the 2001 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences650 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2000. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1998–2000, the window the 2001 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1998–2000 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2001. | Compare |
|---|---|---|---|---|---|---|---|
1Annual Review of Plant Physiology and Plant Molecular BiologyAnnual Reviews · United States | 11.11Q1 | 19.09 3.27 up from 2000 | 73 | 3% | — | ||
2CellCell Press · United States | 10.19Q1 | 26.69 4.11 down from 2000 | 1,215 | 94% | $11,400 | ||
3Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 8.65Q1 | 19.14 4.94 up from 2000 | 75 | 7% | $4,500 | ||
4Nature GeneticsNature Portfolio · United States | 8.28Q1 | 19.85 0.12 up from 2000 | 1,060 | 39% | $12,690 | ||
5NatureNature Portfolio · United Kingdom | 6.97Q1 | 9.18 0.07 down from 2000 | 8,837 | 10% | $12,690 | ||
6Annual Review of Biophysics and Biomolecular StructureAnnual Reviews · United States | 6.73Q1 | 15.88 0.74 down from 2000 | 52 | 0% | — | ||
7Molecular CellElsevier BV · United States | 6.12Q1 | 15.88 2.88 down from 2000 | 662 | 100% | $10,400 | ||
8Nature Cell BiologyNature Portfolio · United Kingdom | 5.44Q1 | 14.33 1.65 up from 2000 | 440 | 11% | $12,690 | ||
9Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 5.04Q1 | 12.51 0.39 up from 2000 | 1,479 | 90% | $5,200 | ||
10Biochimica et Biophysica Acta (BBA) - Reviews on BiomembranesElsevier BV · Netherlands | 4.89Q1 | 9.45 2.87 down from 2000 | 42 | — | — | ||
11The EMBO JournalOASpringer Nature · Germany | 4.82Q1 | 12.71 1.67 down from 2000 | 2,054 | 96% | $7,990 | ||
12ScienceAmerican Association for the Advancement of Science · United States | 4.73Q1 | 5.89 0.51 down from 2000 | 12,848 | 3% | — | ||
13Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.38Q1 | 10.24 0.32 down from 2000 | 8,439 | 91% | — | ||
14The Journal of Cell BiologyRockefeller University Press · United States | 4.28Q1 | 11.95 1.54 down from 2000 | 1,677 | 96% | — | ||
15Human Molecular GeneticsOxford University Press · United Kingdom | 3.71Q1 | 9.65 0.10 down from 2000 | 899 | 18% | $4,390 | ||
16Annual Review of BiochemistryAnnual Reviews · United States | 3.66Q1 | 35.16 11.91 down from 2000 | 88 | 4% | — | ||
17Systematic BiologyOxford University Press · United States | 3.63Q1 | 5.99 0.75 up from 2000 | 183 | 23% | $2,166 | ||
18Circulation ResearchLippincott Williams & Wilkins · United States | 3.27Q1 | 8.20 0.19 up from 2000 | 1,096 | 56% | — | ||
19The American Journal of Human GeneticsElsevier BV · United States | 3.22Q1 | 7.66 0.17 down from 2000 | 1,481 | 85% | $5,150 | ||
20Molecular and Cellular BiologyTaylor & Francis · United States | 3.21Q1 | 9.27 0.50 down from 2000 | 2,620 | 99% | — | ||
21Progress in Lipid ResearchElsevier BV · United Kingdom | 3.13Q1 | 4.67 0.82 down from 2000 | 47 | 0% | $5,530 | ||
22American Journal Of PathologyElsevier BV · United States | 2.99Q1 | 6.84 0.52 up from 2000 | 1,112 | 99% | $2,800 | ||
23DevelopmentThe Company of Biologists · United Kingdom | 2.96Q1 | 9.26 0.46 down from 2000 | 1,482 | 7% | — | ||
24TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 2.96Q1 | 3.95 0.83 up from 2000 | 228 | 9% | $5,150 | ||
25Pharmacology & TherapeuticsElsevier BV · United States | 2.79Q1 | 5.17 1.06 down from 2000 | 191 | 3% | $5,660 | ||
26Molecular MicrobiologyWiley · United Kingdom | 2.70Q1 | 6.01 0.24 down from 2000 | 1,503 | 59% | $4,430 | ||
27Progress in Biophysics and Molecular BiologyElsevier BV · United Kingdom | 2.69Q1 | 8.04 2.87 up from 2000 | 79 | 100% | $4,260 | ||
28FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 2.57Q1 | 4.76 0.77 up from 2000 | 199 | 33% | $3,297 | ||
29Cellular MicrobiologyOAWiley · United Kingdom | 2.49Q1 | 4.57 1.45 up from 2000 | 83 | 64% | $2,350 | ||
30The FASEB JournalWiley · United States | 2.48Q1 | 6.40 0.91 up from 2000 | 1,033 | 6% | $3,740 | ||
31Molecular Biology of the CellAmerican Society for Cell Biology · United States | 2.43Q1 | 7.23 0.55 down from 2000 | 945 | 89% | — | ||
32Annual Review of Cell and Developmental BiologyAnnual Reviews · United States | 2.42Q1 | 28.63 1.51 up from 2000 | 66 | 4% | — | ||
33StructureElsevier BV · United Kingdom | 2.41Q1 | 5.66 0.03 up from 2000 | 519 | 100% | $9,350 | ||
34Nature BiotechnologyNature Portfolio · United States | 2.41Q1 | 4.09 0.21 up from 2000 | 1,512 | 17% | $12,690 | ||
35Journal of Biological ChemistryOAElsevier BV · United States | 2.39Q1 | 7.19 0.38 down from 2000 | 15,956 | 100% | $3,430 | ||
36Applied and Environmental MicrobiologyOAAmerican Society for Microbiology · United States | 2.31Q1 | 3.73 0.14 up from 2000 | 2,708 | 95% | — | ||
37Analytical ChemistryAmerican Chemical Society · United States | 2.31Q1 | 3.11 0.13 up from 2000 | 3,812 | 6% | $4,500 | ||
38OncogeneSpringer Nature · United Kingdom | 2.28Q1 | 6.52 0.25 up from 2000 | 2,171 | 5% | $5,990 | ||
39Physiological ReviewsAmerican Physiological Society · United States | 2.28Q1 | 26.45 0.85 up from 2000 | 113 | 7% | — | ||
40Cell Death and DifferentiationSpringer Nature · United Kingdom | 2.27Q1 | 6.37 0.58 down from 2000 | 436 | 12% | $5,790 | ||
41Arteriosclerosis Thrombosis and Vascular BiologyLippincott Williams & Wilkins · United States | 2.25Q1 | 5.26 0.79 up from 2000 | 1,240 | 50% | — | ||
42Molecular Biology and EvolutionOAOxford University Press · United States | 2.21Q1 | 5.35 0.13 up from 2000 | 581 | 73% | $3,418 | ||
43DNA ResearchOAUniversity of Oxford · United Kingdom | 2.17Q1 | 4.03 1.53 down from 2000 | 152 | 100% | $1,400 | ||
44The Journal of Physical Chemistry BAmerican Chemical Society · United States | 2.17Q1 | 3.16 0.22 up from 2000 | 4,787 | 6% | — | ||
45Gene TherapySpringer Nature · United Kingdom | 2.17Q1 | 5.50 0.39 up from 2000 | 751 | 6% | $3,790 | ||
46Current Medicinal ChemistryBentham Science Publishers · Netherlands | 2.13Q1 | 4.41 0.87 up from 2000 | 172 | 0% | — | ||
47Human Gene TherapyMary Ann Liebert, Inc. · United States | 2.11Q1 | 5.36 0.21 down from 2000 | 750 | 3% | — | ||
48Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 2.10Q1 | 4.67 0.08 up from 2000 | 102 | 0% | $4,160 | ||
49Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 2.09Q1 | 4.76 0.11 up from 2000 | 83 | 0% | $5,070 | ||
50Journal of Molecular BiologyElsevier BV · United Kingdom | 2.09Q1 | 6.10 0.73 up from 2000 | 1,606 | 4% | $4,730 |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology546
- Genetics60
- Cancer Research14
- Cell Biology13
- Biophysics6
- Molecular Medicine5
- Biochemistry2
- Clinical Biochemistry2
- Developmental Biology1
- Structural Biology1
- Aging0
- Biotechnology0
- Endocrinology0
- Physiology0
Journals
Citations made in 2001. Corpus-wide, 67.0% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
209 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1998–2000, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2001. Publication window: 1998–2000. How these summaries are calculated
- Ranked journals
- 650
- Window papers (baseline)
- 335,262 Change unavailable from indicator year 1998
- Median OJR
- 0.634 Change unavailable from indicator year 1998
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1998–2000 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.